Calithera Biosciences Inc
NASDAQ:CALA

Watchlist Manager
Calithera Biosciences Inc Logo
Calithera Biosciences Inc
NASDAQ:CALA
Watchlist
Price: 0.02 USD Market Closed
Updated: May 20, 2024

Calithera Biosciences Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Calithera Biosciences Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Calithera Biosciences Inc
NASDAQ:CALA
Accrued Liabilities
$6.7m
CAGR 3-Years
-28%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.1B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.8B
CAGR 3-Years
22%
CAGR 5-Years
39%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
28%

See Also

What is Calithera Biosciences Inc's Accrued Liabilities?
Accrued Liabilities
6.7m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Accrued Liabilities amounts to 6.7m USD.

What is Calithera Biosciences Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
-6%

Over the last year, the Accrued Liabilities growth was -36%. The average annual Accrued Liabilities growth rates for Calithera Biosciences Inc have been -28% over the past three years , -6% over the past five years .